This discussion delves into the potential of Vitamin K2, specifically in its MENATETRENONE MK-4 form, as a treatment for Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). Explore the molecular mechanisms, clinical trials, and personal experiences shared in this informative video. Hit play for the full breakdown.
Watch the full video on YouTube →
Disclosure: This post contains affiliate links. We may earn a commission at no extra cost to you. Prices are accurate as of publication date.